| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.058 | 0.05 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.05 |